Early removal of the etonogestrel contraceptive implant in Spanish women: a prospective cohort study

被引:0
|
作者
Ruiz de Vinaspre-Hernandez, Regina [1 ,2 ]
Garrido-Santamaria, Rosana [3 ]
Urra-Martinez, Raquel [3 ]
Saenz-Cabredo, Paula [4 ]
Garrido-Rivas, Ana Elena [1 ,2 ,4 ]
Juarez-Vela, Raul [1 ,2 ]
Sanchez-Gonzalez, Juan Luis [5 ]
Lafuente-Jimenez, Alberto [4 ]
Ramon-Arbues, Enrique [6 ,7 ]
Navas-Echazarreta, Noelia [1 ,2 ]
Santolalla-Arnedo, Ivan [1 ,2 ]
机构
[1] Univ La Rioja, Fac Hlth Sci, Logrono, Spain
[2] Univ La Rioja, Dept Nursing, Grupac Res Grp, Logrono, Spain
[3] Rioja Hlth Serv, Family Planning Ctr, Logrono, Spain
[4] Rioja Hlth Serv, Logrono, Spain
[5] Univ Salamanca, Dept Nursing & Physiotherapy, Salamanca, Spain
[6] San Jorge Univ, Fac Hlth Sci, Villanueva De Gallego, Spain
[7] Univ Zaragoza, SAPIENF Invest Grp, Zaragoza, Spain
关键词
etonogestrel; contraceptive; implant; early removal; cohort study; CHOICE PROJECT; CONTINUATION;
D O I
10.3389/fmed.2024.1172793
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To know the discontinuation rate and characterize predictors and reasons of contraceptive implant removal within 12 months of insertion in our community setting.Methods This prospective cohort study included women receiving the etonogestrel contraceptive implant at sexual and reproductive health centers between September 2019 and September 2020. The variables collected were implanted insertion timing, reproductive and demographic characteristics, medical conditions, sexual activity and counseling. Our primary outcome was implant discontinuation. Kaplan-Meier survival curves were used to show the cumulative discontinuation rate of implants contraceptive within the first year of insertion. We also identified factors that increased the risk of implant removal using the log-rank test and the Cox regression model. Reasons for discontinuation were documented.Results 199 women were followed up. Implant discontinuation was documented in 17.1% of implant users prior to 12 months. Factors that increase the risk of implant removal are living with a partner, being aged 25-34 years and not receiving comprehensive and structured counseling from the midwife. The main reason for removal was unsatisfactory bleeding (97.1%), but this was combined with other reasons such as cessation of sexual intercourse (58.8%), worsening mood (58.8%), weight gain (55.9%) or decreased libido (50.0%).Conclusion The rate of discontinuous implant uses in the first year is relevant in relation to cost-effectiveness, there is room for improvement that should not be overlooked. Comprehensive and structured midwife-led counseling can reduce early implant abandonment removal. The development in different countries of the role of midwives in the management of contraceptives can contribute to the economic benefit of health services and the satisfaction of women.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study
    Jesus Hernandez-Juarez
    Ethel A Garcia-Latorre
    Manuel Moreno-Hernandez
    Jose Fernando Moran-Perez
    Miguel Angel Rodriguez-Escobedo
    Gerardo Cogque-Hernandez
    Rubén Julián-Nacer
    Xochitl Hernandez-Giron
    Rosalia Palafox-Gomez
    Irma Isordia-Salas
    Abraham Majluf-Cruz
    Reproductive Health, 11
  • [22] A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users
    Lazorwitz, Aaron
    Seale, Rebecca
    Davis, Anne
    Guiahi, Maryam
    CONTRACEPTION, 2020, 102 (01) : 58 - 60
  • [23] Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study
    Sonalkar, Sarita
    Hou, Melody
    Borgatta, Lynn
    CONTRACEPTION, 2013, 88 (05) : 671 - 673
  • [24] Considerations in Adolescent Use of the Etonogestrel Subdermal Implant: A Cohort Study
    Fei, Y. Frances
    Smith, Yolanda R.
    Dendrinos, Melina L.
    Rosen, Monica W.
    Quint, Elisabeth H.
    FRONTIERS IN REPRODUCTIVE HEALTH, 2021, 3
  • [25] Impact of Etonogestrel-releasing contraceptive implant use in cisgender women with Sickle cell disease
    Brito, Milena Bastos
    Boas, Andrea Queiroz Vilas
    Silva, Anelise Maria Nicolau
    Miranda, Flavia Pimentel
    Matos, Carolina Brabec Barreto
    Santos, Oziemile Silva
    da Costa, Tais Paiva
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2024, 116 (05) : 569 - 575
  • [26] Metabolic safety of the etonogestrel contraceptive implant in healthy women over a 3-year period
    Villas-Boas, Jaqueline
    Vilodre, Luiz C.
    Malerba, Helena
    Salcedo, Mila Pontremoli
    Jimenez, Mirela Foresti
    El Beitune, Patricia
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 202 : 51 - 54
  • [27] THE EFFECT OF IMMEDIATE POSTPARTUM VS. INTERVAL INSERTION OF THE ETONOGESTREL CONTRACEPTIVE IMPLANT ON REMOVAL RATES FOR BLEEDING
    Doan, L.
    Goyal, V
    Raker, C.
    Murray, A.
    Allen, R.
    CONTRACEPTION, 2013, 88 (03) : 455 - 455
  • [28] Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant
    Clure, Cara
    Sheeder, Jeanelle
    Lazorwitz, Aaron
    CONTRACEPTION, 2024, 135
  • [29] A prospective pilot study to assess the impact of the etonogestrel implant on postpartum depression
    Ross, Carolyn M.
    Hammond, Cassing
    Ralph, Jessika A.
    Balmert, Lauren C.
    Wisner, Katherine L.
    Kiley, Jessica W.
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2021, 26 (02): : 98 - 104
  • [30] Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year
    Morrell, Kathleen M.
    Cremers, Serge
    Westhoff, Carolyn L.
    Davis, Anne R.
    CONTRACEPTION, 2016, 93 (03) : 263 - 265